Q-Line Biotech IPO
Q-Line Biotech is an NSE SME IPO is priced at ₹326–₹343 per share with an issue size of ₹214.48 crore. The IPO opens on May 21, 2026 and closes on May 25, 2026, with a lot size of 400 shares and a minimum investment of ₹2,74,400.
Q-Line Biotech Limited IPO
- IPO Dates
- May 21, 2026 – May 25, 2026
- Price band
- ₹326-343 per equity share
- Minimum Investment
- ₹2,74,400
- Issue size
- ₹214.48 Cr
- Lot size
- 400
- Allotment Date
- May 26, 2026
- Listing
- May 29, 2026
- Listing At
- NSE SME
IPO timeline
-
May 21, 2026
Open Date
Completed
-
May 25, 2026
Close Date
Completed
-
May 26, 2026
Allotment Date
Completed
-
May 29, 2026
Listing Date
Completed
Q-Line Biotech IPO Expected Premium (Grey Market Trend)
Q-Line Biotech IPO GMP today is ₹100. Grey market premium (GMP) indicates expected listing sentiment.
Q-Line Biotech IPO expected premium (also known as grey market premium or GMP) indicates current market sentiment and potential listing expectations.
Expected Premium provided in this website is derived from market rumors. It is not a guaranteed indicator of the actual listing price and should be interpreted with caution.
Q-Line Biotech IPO Subscription Details
View Subscription DetailsQ-Line Biotech IPO subscription status shows demand across QIB, NII, and retail categories, helping investors understand participation levels.
Last updated:Q-Line Biotech IPO Essentials
Q-Line Biotech IPO Details
Q-Line Biotech IPO is priced at ₹326-343 per share with a total issue size of 214.48 crore. The IPO has a lot size of 400 shares and will be listed on NSE SME.
- Issue price
- ₹326-343 per equity share
- Lot size
- 400 shares
- Face value
- ₹10 Per Equity Share
- Issue size
- 62,53,200 shares(agg. up to ₹214.48 Cr)
- Total issue size
- 62,53,200 shares
(aggregating up to ₹214.48 crore) - Fresh issue
- 62,53,200 shares
(aggregating up to ₹214.48 crore) - Listing at
- NSE SME
- Listing date
- Registrar
- Purva Sharegistry (India) Pvt.Ltd.
- Lead manager
-
Hem Securities Ltd., Share India Capital Services Pvt.Ltd.
Market Lot Size
Investors can bid for a minimum of 800 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual (min) | 2 | 800 | ₹2,74,400 |
| Individual(max) | 2 | 800 | ₹2,74,400 |
| sHNI(min) | 3 | 1,200 | ₹4,11,600 |
| sHNI(max) | 7 | 2,800 | ₹9,60,400 |
| sHNI(min) | 8 | 3,200 | ₹10,97,600 |
Q-Line Biotech IPO Reservation
Q-Line Biotech IPO reservation details show category-wise allocation of shares. Out of the total 6253200 shares, approximately 20% are reserved for QIB, 14.44% for NII, 33.25% for retail investors, 5.01% for market maker, and 27.11% for anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | 1781200 (27.11%) | |
| Market Maker Shares Offered | 313200 (5.01%) | |
| QIB Shares Offered | 1188000 (20%) | |
| NII (HNI) Shares Offered | 891600 (14.44%) | |
| bHNI > ₹10L | 594400 (9.39%) | 495 |
| sHNI < ₹10L | 297200 (4.85%) | 248 |
| Individual Shares Offered | 2079200 (33.25%) | 2599 |
| Total Shares Offered | 6253200 (100%) |
Q-Line Biotech IPO Analytics
Q-Line Biotech IPO category-wise subscription trends show day-wise participation across QIB, NII, and retail investors.
Q-Line Biotech IPO Subscription Status
Q-Line Biotech IPO subscription status shows demand across retail, NII, and QIB categories, helping investors understand overall participation trends.
The IPO is currently subscribed 102.49x, indicating strong demand across investor categories.
| As on | QIB |
NII
bHNI
sHNI
|
Individual | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 11,88,000 |
8,91,600
5,94,400
2,97,200
|
20,79,200 | 41,58,800 |
|
Day 1
21-05-26 05:00 PM
|
4.15 x |
5.25x
5.85x
4.07x
|
3.66 x | 4.14 x |
|
Day 2
22-05-26 05:00 PM
|
5.19 x |
15.96x
18.49x
10.92x
|
9.98 x | 9.90 x |
|
Day 3
25-05-26 05:00 PM
|
123.94 x |
146.33x
178.82x
81.35x
|
71.44 x | 102.49 x |
|
Total No. of Applications
|
bHNI | sHNI | Individual |
|---|---|---|---|
| 235644 (Approx) | 62.95x | 75.08x | 71.44x |
Q-Line Biotech Valuations
Earnings
- EPS Pre IPO
- ₹16.47/-
- EPS Post IPO
- ₹22.12/-
- P/E Pre IPO
- 20.82
- P/E Post IPO
- 15.51
Returns
- ROE
- 16.88%
- ROCE
- 13.32%
- RoNW
- 16.88%
- PAT Margin
- 16.65%
Fundamentals
- Debt / Equity
- 1.06
- Price / Book
- 2.44
- Market Cap
- ₹800.16 Cr.
Q-Line Biotech Financials( In Crs.)
| 31-Dec-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|---|
| Assets | 561.34 | 455.49 | 339.25 | 251.58 |
| Revenue | 236.50 | 322.58 | 206.45 | 184.81 |
| Profit After Tax | 38.69 | 28.13 | 34.44 | 32.10 |
| Total Borrowing | 243.85 | 164.95 | 96.91 | 73.65 |
Q-Line Biotech Company & Offer Insights
About Q-Line Biotech
Founded in 2010, Q-Line Biotech Ltd. is involved in the development, manufacture and commercialization of various reagents (kits and POC devices) and consumables and manufacturing, importation, and supply of diagnostic instruments for different healthcare requirements.
Q-Line Biotech Ltd. has been providing diagnostic instruments and IVD products for different healthcare requirements since 2013 either directly or via our distributor(s) primarily to diagnostic service organizations, hospitals, and medical colleges.
Q-Line Biotech Ltd.'s manufacturing categories comprise indigenous manufacture of reagents including Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics, and Others (POC Devices & Rapid Tests) and supply/ manufacture of in vitro diagnostics (IVD), pathology equipment and devices.
As of March 31, 2025, the company employed 313 permanent employees.
Q-Line Biotech Promoter(s)
Saurabh Garg, Amita Garg, Ayush Garg, Ajay Kumar Mahanty, Abhay Agrawal are the company's promoters of Q-Line Biotech.
Q-Line Biotech IPO Issue Objectives
- •
- To meet Working Capital requirements - ₹93.50 Cr.
- •
- Repayment of certain borrowing availed by the Company, in part or full - ₹90.0 Cr.
- •
- General corporate purposes
Contact Information
Contact Details
Q-Line Biotech
+91 522-2435570
298-281, Transport Nagar, Kanpur Road Adjacent Transport Nagar Metro Station, Lucknow, Uttar Pradesh - 226012.
Registrar Contact Details
Purva Sharegistry India Pvt Ltd
+91-022-23018261/ 23016761
Frequently Asked Questions
Click any question to reveal the answer
Q-Line Biotech IPO is a book-built IPO worth ₹214.48 crore. The price band is ₹326–₹343 per share. The IPO opens on May 21, 2026 and closes on May 25, 2026. It will be listed on NSE SME Platform. Purva Sharegistry (India) Pvt. Ltd. is the registrar.
The price band of Q-Line Biotech IPO is ₹326 to ₹343 per share.
The lot size of Q-Line Biotech IPO is 400 shares.
The minimum investment for Q-Line Biotech IPO is approximately ₹2,74,400 based on the upper price band .
Q-Line Biotech IPO opens on May 21, 2026 and closes on May 25, 2026.
The allotment date of Q-Line Biotech IPO is May 26, 2026.
Q-Line Biotech IPO is expected to be listed on May 29, 2026, on NSE SME Platform.
The Grey Market Premium (GMP) for Q-Line Biotech IPO is ₹100-104 as of May 27, 2026. Based on the upper price band of ₹343, the estimated listing price is ₹443, representing a potential gain of approximately 29%.
Q-Line Biotech IPO valuation snapshot: P/E 15.51, EPS ₹22.12/-, P/B 2.44, RoNW 16.88%, and market cap ₹800.16 Cr.
To apply for Q-Line Biotech IPO, open the IPO Ji app or website, select the IPO, choose your demat account, enter the quantity, and submit the application.
You can check the live subscription status of Q-Line Biotech IPO on IPO Ji or stock exchange websites. It shows real-time demand across retail, NII, and QIB categories.
Pre-apply allows investors to submit their IPO application before the bidding period starts. The order is placed automatically when the IPO opens.
If you pre-apply for Q-Line Biotech IPO, your order will be placed when the IPO bidding starts, and a UPI mandate request will be generated.
You can check Q-Line Biotech IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Q-Line Biotech IPO allotment status on IPO Ji for quick and easy access.